Form 4 for MXCT MAXCYTE, INC.
Accepted 2024-06-13 00:00:00 ET · period of report 2024-06-11 · accession 0001415889-24-016711 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-13 | 2024-06-11 | MXCT | Erck Stanley C | Dir | A - Grant | $0.00 | +21.4K | 269.1K | +9% | $0 |
| D | 2024-06-13 | 2024-06-11 | MXCT | Erck Stanley C | Dir | A - Grant | $0.00 | +40.7K | 40.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-11 | A | A | 21,367 | $0.00 | 269,118 | D | — | — | (F1) These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F2) This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2024-06-11 | A | A | 40,701 | $0.00 | 40,701 | D | $4.68 · — to 2034-06-10 | 40,701 Common Stock | (F2) This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. |